BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28632727)

  • 1. Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas.
    Presneau N; Duhamel LA; Ye H; Tirabosco R; Flanagan AM; Eskandarpour M
    Br J Cancer; 2017 Jul; 117(3):398-408. PubMed ID: 28632727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
    Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1.
    Ying S; Jianjun H; Xue Y; Shuwei Y; Liyuan Z; Jie W; Lixian C
    Oncol Res; 2017 Nov; 25(9):1421-1430. PubMed ID: 28059051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
    Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
    J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 promotes metastasis of human osteosarcoma cells.
    Zhang N; Xie T; Xian M; Wang YJ; Li HY; Ying MD; Ye ZM
    Oncotarget; 2016 Nov; 7(48):79654-79669. PubMed ID: 27793039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
    Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial SIRT1 prevents adverse arterial remodeling by facilitating HERC2-mediated degradation of acetylated LKB1.
    Bai B; Man AW; Yang K; Guo Y; Xu C; Tse HF; Han W; Bloksgaard M; De Mey JG; Vanhoutte PM; Xu A; Wang Y
    Oncotarget; 2016 Jun; 7(26):39065-39081. PubMed ID: 27259994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma.
    Takeda S; Iwai A; Nakashima M; Fujikura D; Chiba S; Li HM; Uehara J; Kawaguchi S; Kaya M; Nagoya S; Wada T; Yuan J; Rayter S; Ashworth A; Reed JC; Yamashita T; Uede T; Miyazaki T
    Anticancer Res; 2007; 27(2):761-8. PubMed ID: 17465200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella Typhimurium disrupts Sirt1/AMPK checkpoint control of mTOR to impair autophagy.
    Ganesan R; Hos NJ; Gutierrez S; Fischer J; Stepek JM; Daglidu E; Krönke M; Robinson N
    PLoS Pathog; 2017 Feb; 13(2):e1006227. PubMed ID: 28192515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.
    Chen B; Bao Y; Chen X; Yi J; Liu S; Fang Z; Zheng S; Chen J
    Biomed Pharmacother; 2015 Oct; 75():1-7. PubMed ID: 26463624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells.
    Park SY; Lee HR; Lee WS; Shin HK; Kim HY; Hong KW; Kim CD
    PLoS One; 2016; 11(8):e0160620. PubMed ID: 27494711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
    Liu T; Qin W; Hou L; Huang Y
    Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.
    Lu T; Zhang C; Chai MX; An YB; Jia JL
    Int J Clin Exp Pathol; 2015; 8(9):10776-83. PubMed ID: 26617789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
    Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
    Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.
    Yang G; Zhang P; Lv A; Liu Y; Wang G
    Exp Mol Pathol; 2016 Feb; 100(1):160-6. PubMed ID: 26708425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.